title: Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis.
authors: E
authors: E
authors: Rallis
authors: G
authors: G
authors: Papatheodorou
authors: E
authors: E
authors: Bimpakis
authors: D
authors: D
authors: Butanska
authors: P
authors: P
authors: Menounos
authors: P
authors: P
authors: Papadakis
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000188:drug therapy*; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male
chemical_list: D003879:Dermatologic Agents; D015474:Isotretinoin